<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_full.rss">
    <title>Pharmaceutical Technology Magazine</title>

    <link>http://pharmtech.findpharma.com/pharmtech</link>

    <description>A publication providing practical information on pharmaceutical manufacturing. Content focuses on
    applied R&amp;amp;D technology, process control and computer-integrated manufacturing, biotechnology and technical
    management.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Sizing-Up-the-CDMO-Market/ArticleStandard/Article/detail/639786?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/SOCMA-petition-reveals-disparity-of-FDA-inspection/ArticleStandard/Article/detail/639161?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Illegal-equipment-puts-pharma-workers-in-danger/ArticleStandard/Article/detail/639158?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/10-new-orphan-products-a-year-between-2009-and-201/ArticleStandard/Article/detail/639157?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/New-biopharm-pumps-with-extensive-documentation-pa/ArticleStandard/Article/detail/639925?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Lonza-plans-cost-reductions/ArticleStandard/Article/detail/639163?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Novartis-to-invest-1-billion-in-China-RampD-instit/ArticleStandard/Article/detail/639159?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Broken-biopharm/ArticleStandard/Article/detail/639155?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/New-speciality-pharma-company-formed-in-Sweden/ArticleStandard/Article/detail/639927?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/New-biopharm-portal-brings-clarity-to-equipment-GM/ArticleStandard/Article/detail/639915?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/USP-revises-excipient-standards-to-limit-contamina/ArticleStandard/Article/detail/639165?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/ICH-prepares-for-global-quality-implementation/ArticleStandard/Article/detail/639164?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Light-activated-gold-cage-delivery-capsule-develop/ArticleStandard/Article/detail/639156?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Regulatory-Roundup-FDA-Issues-Guidance-on-In-Vitro/ArticleStandard/Article/detail/639001?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-To-Invest-1-Billion-in-China-RampD-Instit/ArticleStandard/Article/detail/638992?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Europe-May-See-10-New-Orphan-Products-a-Year/ArticleStandard/Article/detail/638999?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Lonza-Restructures-Plans-Cost-Reductions/ArticleStandard/Article/detail/639210?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Advancing-Chiral-Chemistry-in-API-Synthesis/ArticleStandard/Article/detail/639207?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Whatever-Happened-to-Classical-Chemistry/ArticleStandard/Article/detail/639203?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Safety-versus-Speed-in-Drug-Development/ArticleStandard/Article/detail/639197?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Report-from-the-Philippines/ArticleStandard/Article/detail/639208?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Hans-Engels-of-DSM-Pharmaceuticals/ArticleStandard/Article/detail/639989?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Facing-Reality/ArticleStandard/Article/detail/639202?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639193?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Position-Paper-Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639199?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/whitepaper-alert/ArticleStandard/Article/detail/638549?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/esolution-broadcast-2/ArticleStandard/Article/detail/638542?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Changes-for-Better-or-Worse/ArticleStandard/Article/detail/639201?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Moisture-Activated-Dry-GranulationmdashPart-I-A-Gu/ArticleStandard/Article/detail/639196?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Insider-Solutions-A-New-Direction-for-USP/ArticleStandard/Article/detail/639205?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Preventing-counterfeits-from-entering-the-supply-c/ArticleStandard/Article/detail/635815?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/ArticleStandard/Article/detail/637631?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/A-novel-drug-detection-technology/ArticleStandard/Article/detail/631248?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sustainability-in-the-packaging-supply-chain/ArticleStandard/Article/detail/631118?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Trends-in-labelling/ArticleStandard/Article/detail/637632?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Case-study-printing-powders-with-Sticky-Web-techno/ArticleStandard/Article/detail/637639?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-challenges-of-inhaler-testing/ArticleStandard/Article/detail/636406?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Packaging-the-experts-view/ArticleStandard/Article/detail/637634?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Demographic-time-bomb/ArticleStandard/Article/detail/637635?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Neal-Dunkinson-151-Up-to-date-business-planning/ArticleStandard/Article/detail/634870?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Change-presents-an-opportunity-for-new-partnership/ArticleStandard/Article/detail/635590?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/The-pharmaceutical-packaging-market/ArticleStandard/Article/detail/637640?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing/Reality-not-insanity/ArticleStandard/Article/detail/637636?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/USPs-Ferrules-and-Caps-Labeling-Changes-Put-on-Hol/ArticleStandard/Article/detail/638764?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Challenges-and-Strategies-for-Implementing-Automat/ArticleStandard/Article/detail/638760?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peter-Soelkner-of-Vetter/ArticleStandard/Article/detail/635816?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Is-EU-pharma-ready-for-Braille-embossing/ArticleStandard/Article/detail/634891?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Targeting-Therapeutics-for-the-Middle-and-Inner-Ea/ArticleStandard/Article/detail/638761?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation/Current-Perspectives-on-Aseptic-Formulations/ArticleStandard/Article/detail/638763?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Editor%27s+comment/Have-your-say/ArticleStandard/Article/detail/637630?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Report-calls-out-FDAs-poor-oversight-of-accelerate/ArticleStandard/Article/detail/637071?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/US-Chemical-manufacturers-raise-concerns-over-mand/ArticleStandard/Article/detail/637073?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Most+Viewed+Articles/Pfizer-accused-of-corporate-arrogance/ArticleStandard/Article/detail/637074?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Generic-APIs-outstrip-innovation/ArticleStandard/Article/detail/637069?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/FDA-tracks-influenza-A-treatment-with-prescription/ArticleStandard/Article/detail/637072?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Cargill-updates-industry-on-portfolio-innovations/ArticleStandard/Article/detail/637079?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Residual-Solvents-Alternate-Validated-Methods/ArticleStandard/Article/detail/637714?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Residual-Solvents-Alternate-Validated-Methods---La/ArticleStandard/Article/detail/637563?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/GAO-Report-Calls-Out-FDAs-Poor-Oversight-of-Accele/ArticleStandard/Article/detail/637175?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Generic-APIs-Outstrip-Innovation/ArticleStandard/Article/detail/637179?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Rapid-Growth-of-Full-Time-Equivalent-Staffing-Prog/ArticleStandard/Article/detail/637729?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Tracks-Influenza-A-Treatment-with-Prescription/ArticleStandard/Article/detail/637177?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Online+Only/Regulatory-Roundup-FDA-Authorizes-Emergency-Use-of/ArticleStandard/Article/detail/637172?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Rapid-Growth-of-Full-Time-Equivalent-Staffing-Prog/ArticleStandard/Article/detail/637543?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/House-Committee-Passes-IST-Requirements-in-Chemica/ArticleStandard/Article/detail/637178?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Barcode-technology-addresses-the-counterfeit-dilem/ArticleStandard/Article/detail/637255?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Product-profile/ArticleStandard/Article/detail/636757?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Pharmaceutical-Technology-Podcast-Series-on-Supply/ArticleStandard/Article/detail/636866?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Design-Space-Development-Design-for-Manufacturing-/ArticleStandard/Article/detail/636616?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/ERP-strategies-and-Best-Practices-for-Emerging-Lif/ArticleStandard/Article/detail/636536?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Generics-prevent-innovations-in-pharma/ArticleStandard/Article/detail/635260?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Counterfeit-medicines-more-profitable-than-heroin/ArticleStandard/Article/detail/635259?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/FDA-new-guidance-on-drug-labeling-and-pharmacologi/ArticleStandard/Article/detail/635283?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Pfizer-and-Wyeth-begin-operations-as-a-combined-co/ArticleStandard/Article/detail/635469?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Charged-Aerosol-Detection-in-Pharmaceutical-Analys/ArticleStandard/Article/detail/636147?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Uniting-all-CROs/ArticleStandard/Article/detail/635281?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/EFCG-Counterfeit-Medicines-More-Profitable-than-He/ArticleStandard/Article/detail/635540?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/e-solution-broadcast/ArticleStandard/Article/detail/636004?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Pharm-Tech-custom-e-newsletter/ArticleStandard/Article/detail/635994?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Pfizer-and-Wyeth-Begin-Operations-as-a-Combined-Co/ArticleStandard/Article/detail/635536?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/Regulatory-Roundup-FDA-and-FTC-Issue-Joint-Warning/ArticleStandard/Article/detail/635530?ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-New-Guidance-on-Drug-Labeling-and-Pharm/ArticleStandard/Article/detail/635534?ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-07T15:57:08Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Sizing-Up-the-CDMO-Market/ArticleStandard/Article/detail/639786?ref=25">

    <title>Sizing Up the CDMO Market</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Sizing-Up-the-CDMO-Market/ArticleStandard/Article/detail/639786?ref=25</link>

    <description>A new analysis highlights growth drivers and challenges for clinical supply-chain
    services.</description>

    <dc:date>2009-11-10T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639786null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/SOCMA-petition-reveals-disparity-of-FDA-inspection/ArticleStandard/Article/detail/639161?ref=25">

    <title>SOCMA petition reveals disparity of FDA inspections</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/SOCMA-petition-reveals-disparity-of-FDA-inspection/ArticleStandard/Article/detail/639161?ref=25</link>

    <description>The FDA has responded to a citizen petition from the Society of Chemical Manufacturers and Affiliates
    (SOCMA) that highlighted the disparity in inspections of domestic and foreign drug-manufacturing
    facilities.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639161null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Illegal-equipment-puts-pharma-workers-in-danger/ArticleStandard/Article/detail/639158?ref=25">

    <title>Illegal equipment puts pharma workers in danger</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Illegal-equipment-puts-pharma-workers-in-danger/ArticleStandard/Article/detail/639158?ref=25</link>

    <description>The prevalence of substandard or counterfeit safety products and personal protective equipment (PPE)
    has become a &amp;#34;very serious&amp;#34; problem in the UK, according to the British Safety Industry Federation
    (BSIF), and could be putting workers in the pharma industry at risk.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639158null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/10-new-orphan-products-a-year-between-2009-and-201/ArticleStandard/Article/detail/639157?ref=25">

    <title>10 new orphan products a year between 2009 and 2019</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/10-new-orphan-products-a-year-between-2009-and-201/ArticleStandard/Article/detail/639157?ref=25</link>

    <description>The European Organisation for Rare Diseases (EURORDIS) has predicted that 100 new designated orphan
    products will receive marketing authorization between 2009 and 2019, which equates to approximately 10 new products
    every year.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639157null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/New-biopharm-pumps-with-extensive-documentation-pa/ArticleStandard/Article/detail/639925?ref=25">

    <title>New biopharm pumps with extensive documentation package</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/New-biopharm-pumps-with-extensive-documentation-pa/ArticleStandard/Article/detail/639925?ref=25</link>

    <description>Alfa Laval has added two new biopharm pumps to its offering and can now meet a wider selection of
    customer needs at differentiated prices.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639925null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Lonza-plans-cost-reductions/ArticleStandard/Article/detail/639163?ref=25">

    <title>Lonza plans cost reductions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Lonza-plans-cost-reductions/ArticleStandard/Article/detail/639163?ref=25</link>

    <description>Lonza (Switzerland) has announced a series of cost-cutting measures for the next
    12&amp;amp;not;&amp;amp;#150;18 months.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639163null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Novartis-to-invest-1-billion-in-China-RampD-instit/ArticleStandard/Article/detail/639159?ref=25">

    <title>Novartis to invest $1 billion in China R&amp;amp;amp;D institute</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Novartis-to-invest-1-billion-in-China-RampD-instit/ArticleStandard/Article/detail/639159?ref=25</link>

    <description>Novartis (Switzerland) plans to invest $1 billion during the next 5 years to increase R&amp;amp;amp;D
    activities in China, including a significant expansion of The Novartis Institute of BioMedical Research (CNIBR) in
    Shanghai.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639159null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Broken-biopharm/ArticleStandard/Article/detail/639155?ref=25">
    <title>Broken biopharm</title>

    <link>http://pharmtech.findpharma.com/pharmtech/Broken-biopharm/ArticleStandard/Article/detail/639155?ref=25</link>

    <description>The engine of biopharmaceutical innovation is broken, according to Eli Lilly's Chairman and CEO, John
    C. Lechleiter.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639155null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/New-speciality-pharma-company-formed-in-Sweden/ArticleStandard/Article/detail/639927?ref=25">

    <title>New speciality pharma company formed in Sweden</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/New-speciality-pharma-company-formed-in-Sweden/ArticleStandard/Article/detail/639927?ref=25</link>

    <description>A new pharmaceutical company with a focus on rare diseases has been formed in Sweden following the
    merger of the Swedish companies Biovitrum and Swedish Orphan.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639927null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/New-biopharm-portal-brings-clarity-to-equipment-GM/ArticleStandard/Article/detail/639915?ref=25">

    <title>New biopharm portal brings clarity to equipment GMPs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/New-biopharm-portal-brings-clarity-to-equipment-GM/ArticleStandard/Article/detail/639915?ref=25</link>

    <description>A site designed to take the mystery out of biopharm equipment selection, GMP concepts and good
    engineering practice.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639915null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/USP-revises-excipient-standards-to-limit-contamina/ArticleStandard/Article/detail/639165?ref=25">

    <title>USP revises excipient standards to limit contamination</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/USP-revises-excipient-standards-to-limit-contamina/ArticleStandard/Article/detail/639165?ref=25</link>

    <description>In response to a request from the FDA, the US Pharmacopeial Convention (USP) has revised its standards
    for propylene glycol and sorbitol solution, excipients widely used in prescription and over-the-counter
    drugs.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639165null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/ICH-prepares-for-global-quality-implementation/ArticleStandard/Article/detail/639164?ref=25">

    <title>ICH prepares for global quality implementation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/ICH-prepares-for-global-quality-implementation/ArticleStandard/Article/detail/639164?ref=25</link>

    <description>The International Conference on Harmonization (ICH) has adopted pharmacopeial text annexes after a
    meeting of the steering committee and expert working groups last week.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639164null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Light-activated-gold-cage-delivery-capsule-develop/ArticleStandard/Article/detail/639156?ref=25">

    <title>Light-activated gold cage delivery capsule developed</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Light-activated-gold-cage-delivery-capsule-develop/ArticleStandard/Article/detail/639156?ref=25</link>

    <description>A smart nanocage that can be filled with a medicinal substance and then activated using light has been
    developed by US researchers.</description>

    <dc:date>2009-11-06T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639156null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Regulatory-Roundup-FDA-Issues-Guidance-on-In-Vitro/ArticleStandard/Article/detail/639001?ref=25">

    <title>Regulatory Roundup: FDA Issues Guidance on In Vitro Diagnostic 2009 H1N1 Tests, More....</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Regulatory-Roundup-FDA-Issues-Guidance-on-In-Vitro/ArticleStandard/Article/detail/639001?ref=25</link>

    <description>Also, FDA and WebMD increase collaboration and PPD is awarded contract to evaluate the agency's
    postmarket spontaneous-adverse-event surveillance system.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639001null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-To-Invest-1-Billion-in-China-RampD-Instit/ArticleStandard/Article/detail/638992?ref=25">

    <title>Novartis To Invest $1 Billion in China R&amp;amp;amp;D Institute</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Novartis-To-Invest-1-Billion-in-China-RampD-Instit/ArticleStandard/Article/detail/638992?ref=25</link>

    <description>Novartis (Basel, Switzerland) plans to invest $1 billion over the next five years to increase research
    and development activities in China, including a significant expansion of The Novartis Institute of BioMedical
    Research (CNIBR) in Shanghai.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638992null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?ref=25">

    <title>SOCMA Hails FDA Action on Citizen Petition Regarding Inspections</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?ref=25</link>

    <description>The Society of Chemical Manufacturers and Affiliates (SOCMA) reported last week that the US Food and
    Drug Administration responded to the association's citizen petition relating to the inspection process of foreign
    drug-manufacturing facilities.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639211null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?ref=25">

    <title>ICH Adopts Pharmacopeial Text Annexes and Prepares for Global Quality Implementation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?ref=25</link>

    <description>Last week, the steering committee and expert working groups of the International Conference on
    Harmonization (ICH) met in St. Louis, Missouri. A major success of the meeting was the adoption of several annexes
    to ICH Q4B on pharmacopeial texts.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638997null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?ref=25">

    <title>USP Revises Excipient Standards to Limit Contamination</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Revises-Excipient-Standards-to-Limit-Contamina/ArticleStandard/Article/detail/639036?ref=25</link>

    <description>In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention
    (USP) revised its standards for propylene glycol and sorbitol solution</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639036null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?ref=25">

    <title>Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson &amp;amp;amp; Johnson Announces Restructuring;
    PPD Acquires Chinese CRO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?ref=25</link>

    <description>Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its
    business team.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Europe-May-See-10-New-Orphan-Products-a-Year/ArticleStandard/Article/detail/638999?ref=25">

    <title>Europe May See 10 New Orphan Products a Year</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Europe-May-See-10-New-Orphan-Products-a-Year/ArticleStandard/Article/detail/638999?ref=25</link>

    <description>The European Organization for Rare Diseases (EURORDIS) predicts that 100 new designated orphan
    products will receive marketing authorization between 2009 and 2019, which equates to approximately 10 new products
    every year.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638999null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Lonza-Restructures-Plans-Cost-Reductions/ArticleStandard/Article/detail/639210?ref=25">

    <title>Lonza Restructures, Plans Cost Reductions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Lonza-Restructures-Plans-Cost-Reductions/ArticleStandard/Article/detail/639210?ref=25</link>

    <description>Lonza (Basel, Switzerland), the large contract manufacturer of small-molecule and biologic-based
    active pharmaceutical ingredients (APIs), announced last week a series of cost-cutting measures for the next 12 to
    18 months.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639210null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Advancing-Chiral-Chemistry-in-API-Synthesis/ArticleStandard/Article/detail/639207?ref=25">

    <title>Advancing Chiral Chemistry in API Synthesis</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients+Insider/Advancing-Chiral-Chemistry-in-API-Synthesis/ArticleStandard/Article/detail/639207?ref=25</link>

    <description>Functionalized supramolecular catalysts and an enantioselective route to unnatural amino acids are
    some recent developments.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639207/pt-1109-p44-Ingredients_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639207null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?ref=25">

    <title>Stay Afloat with Lessons Learned</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?ref=25</link>

    <description>FDA's Edwin Rivera-Martinez on dodging supply-chain challenges.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?ref=25">

    <title>Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?ref=25</link>

    <description>The authors, representing the International Pharmaceutical Excipients Council, propose a new
    evaluation procedure, including tiered toxicology testing for excipients.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639204null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Whatever-Happened-to-Classical-Chemistry/ArticleStandard/Article/detail/639203?ref=25">

    <title>Whatever Happened to Classical Chemistry?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Whatever-Happened-to-Classical-Chemistry/ArticleStandard/Article/detail/639203?ref=25</link>

    <description>A recent book reminds readers that small-molecule chemistry has enabled advances in
    biotechnology.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203/pt-1109-Vetterlein-book-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639203null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Safety-versus-Speed-in-Drug-Development/ArticleStandard/Article/detail/639197?ref=25">

    <title>Safety versus Speed in Drug Development</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Safety-versus-Speed-in-Drug-Development/ArticleStandard/Article/detail/639197?ref=25</link>

    <description>The heightened focus on risk raises concerns about delays in approving new drugs.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639197null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Report-from-the-Philippines/ArticleStandard/Article/detail/639208?ref=25">

    <title>Report from: the Philippines</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Report-from-the-Philippines/ArticleStandard/Article/detail/639208?ref=25</link>

    <description>New pricing controls and healthcare reforms may be pushing the pharmaceutical market out of this
    southeast Asian country. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639208/pt-1109-Philippines-p18_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639208/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639208null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Hans-Engels-of-DSM-Pharmaceuticals/ArticleStandard/Article/detail/639989?ref=25">

    <title>Q&amp;amp;amp;A with Hans Engels, Business Unit President and CEO of DSM Pharmaceuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Hans-Engels-of-DSM-Pharmaceuticals/ArticleStandard/Article/detail/639989?ref=25</link>

    <description>Engels discusses the latest industry developments and trends.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639989/P90.-Q&amp;A_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639989null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Facing-Reality/ArticleStandard/Article/detail/639202?ref=25">

    <title>Facing Reality</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Outlook/Facing-Reality/ArticleStandard/Article/detail/639202?ref=25</link>

    <description>Contract organizations waiting for the pipeline to come roaring back are kidding
    themselves.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639202null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639193?ref=25">

    <title>Are We Abandoning IQ and OQ?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639193?ref=25</link>

    <description>New standards may overlook critical qualification needs.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639193null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Position-Paper-Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639199?ref=25">

    <title>Position Paper: Are We Abandoning IQ and OQ?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Position-Paper-Are-We-Abandoning-IQ-and-OQ/ArticleStandard/Article/detail/639199?ref=25</link>

    <description>The author explores differences between two qualification documents, the draft guidance from FDA
    &amp;#34;Process Validation: General Principles and Practice&amp;#34; and the ASTM E2500-7 standard &amp;#34;Guide
    for Specification, Design, and Verification of Pharmaceutical and Biopharmaceutical Manufacturing Systems and
    Equipment.&amp;#34;</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639199/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639199null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?ref=25">

    <title>A Robust, Automated Karl Fischer Titration System</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?ref=25</link>

    <description>The authors developed a robust, automated system to conduct Karl Fischer moisture assays for
    lyophilized products.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639198/pt-1109-fig-2-p58B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639198null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/whitepaper-alert/ArticleStandard/Article/detail/638549?ref=25">
    <title>whitepaper alert</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/whitepaper-alert/ArticleStandard/Article/detail/638549?ref=25</link>

    <description>white paper alert</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638549null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/esolution-broadcast-2/ArticleStandard/Article/detail/638542?ref=25">

    <title>esolution broadcast 2</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/esolution-broadcast-2/ArticleStandard/Article/detail/638542?ref=25</link>

    <description>esolution broadcast 2</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638542null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Changes-for-Better-or-Worse/ArticleStandard/Article/detail/639201?ref=25">

    <title>Changes for Better or Worse</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Changes-for-Better-or-Worse/ArticleStandard/Article/detail/639201?ref=25</link>

    <description>New tests solve one issue, but cheaper plastic and new stoppers cause problems.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639201null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?ref=25">

    <title>Sharing Supply-Chain Security</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?ref=25</link>

    <description>A panel of industry and regulatory experts, including FDA, discuss efforts to secure the global
    pharmaceutical supply chain. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/pt1109_coverstory_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Moisture-Activated-Dry-GranulationmdashPart-I-A-Gu/ArticleStandard/Article/detail/639196?ref=25">

    <title>Moisture-Activated Dry Granulation&amp;amp;mdash;Part I: A Guide to Excipient and Equipment Selection and
    Formulation Development</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Moisture-Activated-Dry-GranulationmdashPart-I-A-Gu/ArticleStandard/Article/detail/639196?ref=25</link>

    <description>The authors explain a process for moisture-activated dry granulation in detail and provide guidance
    for the selection of excipients and equipment.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639196/pt1109-fig-1-P64B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639196null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?ref=25">

    <title>DIY Healthcare Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?ref=25</link>

    <description>While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the
    game too.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Insider-Solutions-A-New-Direction-for-USP/ArticleStandard/Article/detail/639205?ref=25">

    <title>Insider Solutions: A New Direction for USP?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Insider-Solutions-A-New-Direction-for-USP/ArticleStandard/Article/detail/639205?ref=25</link>

    <description>With a five-yar revision cycle around the corner, USP will hit or miss the collaboration
    mark.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639205null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639200null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Preventing-counterfeits-from-entering-the-supply-c/ArticleStandard/Article/detail/635815?ref=25">

    <title>Preventing counterfeits from entering the supply chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Preventing-counterfeits-from-entering-the-supply-c/ArticleStandard/Article/detail/635815?ref=25</link>

    <description>With counterfeit drugs on the rise, the Chairman and CEO of Ahura Scientific discusses the issue and
    explains how a handheld device is helping companies to tackle the problem.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635815/doug_thumbnail_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635815null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item rdf:about="http://pharmtech.findpharma.com/pharmtech/News/ArticleStandard/Article/detail/637631?ref=25">
    <title>News</title>

    <link>http://pharmtech.findpharma.com/pharmtech/News/ArticleStandard/Article/detail/637631?ref=25</link>

    <description>A round-up of news from across the industry.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637631null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/A-novel-drug-detection-technology/ArticleStandard/Article/detail/631248?ref=25">

    <title>A novel drug detection technology</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/A-novel-drug-detection-technology/ArticleStandard/Article/detail/631248?ref=25</link>

    <description>Researchers at the University of Leicester (UK) have combined crime research and space-age technology
    to create a new method of detecting counterfeit pharmaceuticals. The technique, Spectral ID, works by detecting the
    differences between the characteristics of light reflected from printed packaging.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631248null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sustainability-in-the-packaging-supply-chain/ArticleStandard/Article/detail/631118?ref=25">

    <title>Sustainability in the packaging supply chain</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Sustainability-in-the-packaging-supply-chain/ArticleStandard/Article/detail/631118?ref=25</link>

    <description>Michael Rubenstein, Chief Growth and Innovation Officer at Alcan Packaging, talks about applying a
    philosophy of sustainability to the pharmaceutical packaging supply chain.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/631118null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Trends-in-labelling/ArticleStandard/Article/detail/637632?ref=25">

    <title>Trends in labelling</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Trends-in-labelling/ArticleStandard/Article/detail/637632?ref=25</link>

    <description>Following years of development, DataMatrix codes are now a viable labelling solution for pharma
    manufacturers.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637632/Beauchamp_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637632null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?ref=25">

    <title>Simplifying data management</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Simplifying-data-management/ArticleStandard/Article/detail/637637?ref=25</link>

    <description>Paper is no longer a sufficient format for information storage and interchange in the pharmaceutical
    industry; documents are inflexible and costly for production and storage.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637637null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?ref=25">

    <title>Developing a modified Pulsincap system</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/Developing-a-modified-Pulsincap-system/ArticleStandard/Article/detail/637638?ref=25</link>

    <description>Chronotherapeutic drug delivery systems (CRDDS) have been recognized as potentially beneficial to the
    chronotherapy (timeoptimized therapy) of widespread chronic diseases that display time-dependent
    symptoms.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637638/Patel_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637638null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Case-study-printing-powders-with-Sticky-Web-techno/ArticleStandard/Article/detail/637639?ref=25">

    <title>Case study: printing powders with Sticky Web technology</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Case-study-printing-powders-with-Sticky-Web-techno/ArticleStandard/Article/detail/637639?ref=25</link>

    <description>GlaxoSmithKline (GSK) appointed 42 Technology (42T) to evaluate existing powder dispensing approaches
    that could be scaled for high speed manufacturing.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637639/CaseStudy_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-challenges-of-inhaler-testing/ArticleStandard/Article/detail/636406?ref=25">

    <title>Regulatory challenges of inhaler testing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Regulatory-challenges-of-inhaler-testing/ArticleStandard/Article/detail/636406?ref=25</link>

    <description>Mark Copley discusses the methods used for DPI testing and the challenges presented by the current
    regulatory framework.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636406/mark_thumbnail_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636406null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Packaging-the-experts-view/ArticleStandard/Article/detail/637634?ref=25">

    <title>Packaging: the experts' view</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Packaging-the-experts-view/ArticleStandard/Article/detail/637634?ref=25</link>

    <description>What trends have you witnessed in the pharmaceutical packaging industry in the last 2
    years?</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637634/Q&amp;A_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637634null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Demographic-time-bomb/ArticleStandard/Article/detail/637635?ref=25">

    <title>Demographic time bomb</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Demographic-time-bomb/ArticleStandard/Article/detail/637635?ref=25</link>

    <description>Population ageing is an issue often discussed in the media, but its impact on all facets of life has
    been poorly characterized.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637635null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Neal-Dunkinson-151-Up-to-date-business-planning/ArticleStandard/Article/detail/634870?ref=25">

    <title>Neal Dunkinson &amp;amp;#151; Up-to-date business planning</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Neal-Dunkinson-151-Up-to-date-business-planning/ArticleStandard/Article/detail/634870?ref=25</link>

    <description>Neal Dunkinson, Commercial Development Manager at CMR International, Thomson Reuters talks about the
    2009 Edition of the CMR International Pharmaceutical R&amp;amp;amp;D Factbook.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/634870/thumbnail_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/634870null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?ref=25">

    <title>Plastic Prefilled Syringes: A Better Fit for Autoinjector Systems</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Plastic-Prefilled-Syringes-A-Better-Fit-for-Autoin/ArticleStandard/Article/detail/638757?ref=25</link>

    <description>The authors describe the ways in which plastic prefilled syringes can be an alternative that provides
    consistent performance, protects drugs prone to degradation, and enhances patient safety.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638757/pt-1109-sup-fig-1-p7B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638757null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Change-presents-an-opportunity-for-new-partnership/ArticleStandard/Article/detail/635590?ref=25">

    <title>Change presents an opportunity for new partnerships</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Change-presents-an-opportunity-for-new-partnership/ArticleStandard/Article/detail/635590?ref=25</link>

    <description>A meeting was recently held in Lindau, Germany, to discuss the changing face of pharma and biotech,
    and how companies can best prepare to face the challenges ahead.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635590/vetter_image_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635590null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/The-pharmaceutical-packaging-market/ArticleStandard/Article/detail/637640?ref=25">

    <title>The pharmaceutical packaging market</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/The-pharmaceutical-packaging-market/ArticleStandard/Article/detail/637640?ref=25</link>

    <description>According to a survey conducted by Pharmaceutical Technology Europe (PTE), almost 50% of you believe
    that cost is the biggest limiting factor to innovation in the pharmaceutical packaging industry.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637640/OpenArticle_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637640null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing/Reality-not-insanity/ArticleStandard/Article/detail/637636?ref=25">

    <title>Reality not insanity</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing/Reality-not-insanity/ArticleStandard/Article/detail/637636?ref=25</link>

    <description>Apopular definition of insanity is repeating the same task over and over again while expecting a
    different result. It would appear, therefore, that many people in the contract services industry think the major
    global bio/pharma companies are insane.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637636null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?ref=25">

    <title>From Needle to Pill: Reformulating Injectable Drugs for Oral Delivery</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/From-Needle-to-Pill-Reformulating-Injectable-Drugs/ArticleStandard/Article/detail/638762?ref=25</link>

    <description>The author describes how Merrion Pharmaceuticals reformulates parenteral drugs into tablets and
    capsules that are easier for patients to take and provide better bioavailability.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638762null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/USPs-Ferrules-and-Caps-Labeling-Changes-Put-on-Hol/ArticleStandard/Article/detail/638764?ref=25">

    <title>USP's Ferrules and Caps Labeling Changes Put on Hold</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/USPs-Ferrules-and-Caps-Labeling-Changes-Put-on-Hol/ArticleStandard/Article/detail/638764?ref=25</link>

    <description>This article provides an update to the author's Viewpoint column, &amp;#34;Changes to Vial Labels May
    Affect Patient Safety,&amp;#34; which ran in Pharmaceutical Technology's March 2009 issue.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638764/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638764null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?ref=25">

    <title>Risk Management for Aseptic Processing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Risk-Management-for-Aseptic-Processing/ArticleStandard/Article/detail/638758?ref=25</link>

    <description>The author discusses the risks involved with aseptic processing, methods and tools used to identify
    and control risk, and regulatory guidelines relevant to the risk-management process.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638758/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638758null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Challenges-and-Strategies-for-Implementing-Automat/ArticleStandard/Article/detail/638760?ref=25">

    <title>Challenges and Strategies for Implementing Automated Visual Inspection for Biopharmaceuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Challenges-and-Strategies-for-Implementing-Automat/ArticleStandard/Article/detail/638760?ref=25</link>

    <description>The authors used a light-transmission-based static division system to detect particles of foreign
    contaminants in prefilled vials.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638760/pt-1109supp-p25-fig1B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638760null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peter-Soelkner-of-Vetter/ArticleStandard/Article/detail/635816?ref=25">

    <title>Peter Soelkner of Vetter</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peter-Soelkner-of-Vetter/ArticleStandard/Article/detail/635816?ref=25</link>

    <description>Peter Soelkner discusses Vetter?s commitment to its clients and the 2nd Vetter Drug Management
    Leadership Conference, 23&amp;amp;#150;24 September 2009, Lindau, Germany.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635816null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Is-EU-pharma-ready-for-Braille-embossing/ArticleStandard/Article/detail/634891?ref=25">

    <title>Is EU pharma ready for Braille embossing?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Industry+Leaders/Is-EU-pharma-ready-for-Braille-embossing/ArticleStandard/Article/detail/634891?ref=25</link>

    <description>In 2010, Braille embossing will be required on all European pharmaceutical packages. Is the industry
    ready?</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/634891/CraigJasper_thumb_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/634891null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?ref=25">

    <title>Technology Forecast for Injectables</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Technology-Forecast-for-Injectables/ArticleStandard/Article/detail/638759?ref=25</link>

    <description>A Conversation with Greystone Associates' George Perros. This article contains bonus online-exclusive
    material.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638759null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Targeting-Therapeutics-for-the-Middle-and-Inner-Ea/ArticleStandard/Article/detail/638761?ref=25">

    <title>Targeting Therapeutics for the Middle and Inner Ear</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Targeting-Therapeutics-for-the-Middle-and-Inner-Ea/ArticleStandard/Article/detail/638761?ref=25</link>

    <description>A Conversation with Otonomy</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638761/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638761null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation/Current-Perspectives-on-Aseptic-Formulations/ArticleStandard/Article/detail/638763?ref=25">

    <title>Current Perspectives on Aseptic Formulations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation/Current-Perspectives-on-Aseptic-Formulations/ArticleStandard/Article/detail/638763?ref=25</link>

    <description>The author details the factors in formulation design, requirements in facilites and equipment, and
    validation criteria for aseptic formualtions.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638763/pt1109-sup-needles-CV-B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638763null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Editor%27s+comment/Have-your-say/ArticleStandard/Article/detail/637630?ref=25">

    <title>Have your say</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Editor%27s+comment/Have-your-say/ArticleStandard/Article/detail/637630?ref=25</link>

    <description>November is finally upon us and the days are getting colder and shorter.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637630null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?ref=25">

    <title>Optimizing drug delivery to the lungs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Optimizing-drug-delivery-to-the-lungs/ArticleStandard/Article/detail/637068?ref=25</link>

    <description>An inhaler mouthpiece that optimizes drug delivery to the lungs and reduces the amount of wasted
    medication has been developed by US researchers.</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637068null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Report-calls-out-FDAs-poor-oversight-of-accelerate/ArticleStandard/Article/detail/637071?ref=25">

    <title>Report calls out FDA's poor oversight of accelerated drug approvals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Report-calls-out-FDAs-poor-oversight-of-accelerate/ArticleStandard/Article/detail/637071?ref=25</link>

    <description>The FDA needs to enhance its oversight of drugs approved on the basis of surrogate endpoints,
    according to a report from the Government Accountability Office (GAO).</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637071null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/US-Chemical-manufacturers-raise-concerns-over-mand/ArticleStandard/Article/detail/637073?ref=25">

    <title>US Chemical manufacturers raise concerns over mandated inherently safe technology</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/US-Chemical-manufacturers-raise-concerns-over-mand/ArticleStandard/Article/detail/637073?ref=25</link>

    <description>The House Energy and Commerce Committee has approved H.R. 2868, the &amp;#34;Chemical Facility
    Anti-Terrorism Act of 2009&amp;#34;, a measure to modify and codify existing requirements of the Chemical Facility
    Anti-Terrorism Standards (CFATS) programme.</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637073null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Most+Viewed+Articles/Pfizer-accused-of-corporate-arrogance/ArticleStandard/Article/detail/637074?ref=25">

    <title>Pfizer accused of corporate arrogance</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Most+Viewed+Articles/Pfizer-accused-of-corporate-arrogance/ArticleStandard/Article/detail/637074?ref=25</link>

    <description>A complaint submitted to the Federal Trade Commission has referred to Pfizer's acquisition of Wyeth as
    &amp;#34;potentially monopolistic&amp;#34; and has urged the Commission to see that &amp;#34;the proposed merger is
    not in the public interest and is in conflict with a wide range of President Obama's
    objectives&amp;#34;.</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637074null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Generic-APIs-outstrip-innovation/ArticleStandard/Article/detail/637069?ref=25">

    <title>Generic APIs outstrip innovation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Generic-APIs-outstrip-innovation/ArticleStandard/Article/detail/637069?ref=25</link>

    <description>The global API market has expanded from $69 billion in 2004 to more than $90 billion in 2008 at an
    average yearly growth rate of 7.2%, according to a report from the Italian Chemical Pharmaceutical Association
    (CPA).</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637069null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/FDA-tracks-influenza-A-treatment-with-prescription/ArticleStandard/Article/detail/637072?ref=25">

    <title>FDA tracks influenza A treatment with prescription data</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/FDA-tracks-influenza-A-treatment-with-prescription/ArticleStandard/Article/detail/637072?ref=25</link>

    <description>The FDA is using prescription data from Wolters Kluwer Pharma Solutions to track the treatment of
    influenza A (H1N1) and other influenza viruses.</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637072null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Cargill-updates-industry-on-portfolio-innovations/ArticleStandard/Article/detail/637079?ref=25">

    <title>Cargill updates industry on portfolio innovations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Cargill-updates-industry-on-portfolio-innovations/ArticleStandard/Article/detail/637079?ref=25</link>

    <description>Cargill has recently announced a number of innovations connected to its range of polyol
    excipients.</description>

    <dc:date>2009-10-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637079null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Residual-Solvents-Alternate-Validated-Methods/ArticleStandard/Article/detail/637714?ref=25">

    <title>Residual Solvents: Alternate Validated Methods</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Residual-Solvents-Alternate-Validated-Methods/ArticleStandard/Article/detail/637714?ref=25</link>

    <description>The USP General Chapter &amp;amp;lt;467&amp;amp;gt; on Residual Solvents became effective on July 1,
    2008. Alternate methods may need to be developed and validated for compounds and any other unlisted solvents used
    in manufacturing that cannot be tested by the General Chapter's GC method. Lancaster Laboratories' analysts have
    been utilizing a technique referred to as a self-validating method. The benefit to this self-validating method
    approach includes a faster timeline and is more cost effective than the traditional approach for clients having a
    short term or infrequent need for testing.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637714null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?ref=25">

    <title>Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&amp;amp;amp;D President;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?ref=25</link>

    <description>Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business
    development, more...</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Residual-Solvents-Alternate-Validated-Methods---La/ArticleStandard/Article/detail/637563?ref=25">

    <title>Residual Solvents: Alternate Validated Methods - Lancaster Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Residual-Solvents-Alternate-Validated-Methods---La/ArticleStandard/Article/detail/637563?ref=25</link>

    <description>Residual Solvents: Alternate Validated Methods - Lancaster Whitepaper</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637563null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/GAO-Report-Calls-Out-FDAs-Poor-Oversight-of-Accele/ArticleStandard/Article/detail/637175?ref=25">

    <title>GAO Report Calls Out FDA's Poor Oversight of Accelerated Drug Approvals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/GAO-Report-Calls-Out-FDAs-Poor-Oversight-of-Accele/ArticleStandard/Article/detail/637175?ref=25</link>

    <description>The US Food and Drug Administration needs to enhance its oversight of drugs approved on the basis of
    surrogate endpoints, according to a September report from the Government Accountability Office (GAO) that was
    released this week.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637175null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Generic-APIs-Outstrip-Innovation/ArticleStandard/Article/detail/637179?ref=25">

    <title>Generic APIs Outstrip Innovation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Generic-APIs-Outstrip-Innovation/ArticleStandard/Article/detail/637179?ref=25</link>

    <description>The global API market has expanded from $69 billion in 2004 to more than $90 billion in 2008,
    according to a report from the Italian Chemical Pharmaceutical Association (CPA); in particular, the report noted a
    rapid growth rate for generic APIs.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637179null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Rapid-Growth-of-Full-Time-Equivalent-Staffing-Prog/ArticleStandard/Article/detail/637729?ref=25">

    <title>Rapid Growth of Full Time Equivalent Staffing Programs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Rapid-Growth-of-Full-Time-Equivalent-Staffing-Prog/ArticleStandard/Article/detail/637729?ref=25</link>

    <description>With the global economy in a recession, a vast majority of pharmaceutical companies are being forced
    to cut costs and control spending. For most companies this means a reduction in workforce and tighter outsourcing
    budgets. Companies are left with the same amount of required laboratory testing, but with fewer employees to
    perform the work in-house. Clients are left searching for value-added programs that will allow them to project all
    of their outsourcing costs for an entire year in order to lock in on set annual costs.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637729null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Tracks-Influenza-A-Treatment-with-Prescription/ArticleStandard/Article/detail/637177?ref=25">

    <title>FDA Tracks Influenza A Treatment with Prescription Data</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Tracks-Influenza-A-Treatment-with-Prescription/ArticleStandard/Article/detail/637177?ref=25</link>

    <description>The US Food and Drug Administration is using prescription data from Wolters Kluwer Pharma Solutions to
    track the treatment of influenza A (H1N1) and other influenza viruses, according to a statement that the company
    released last week.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637177null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Online+Only/Regulatory-Roundup-FDA-Authorizes-Emergency-Use-of/ArticleStandard/Article/detail/637172?ref=25">

    <title>Regulatory Roundup: FDA Authorizes Emergency Use of Investigational Drug for Treatment of Certain H1N1 Flu
    Patients, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Online+Only/Regulatory-Roundup-FDA-Authorizes-Emergency-Use-of/ArticleStandard/Article/detail/637172?ref=25</link>

    <description>Also, FDA's DDMAC issues Warning Letter to King Pharmaceuticals; draft guidance released for SPL
    standards for content of labeling.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637172null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Rapid-Growth-of-Full-Time-Equivalent-Staffing-Prog/ArticleStandard/Article/detail/637543?ref=25">

    <title>Rapid Growth of Full Time Equivalent Staffing Programs - Lancaster Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Rapid-Growth-of-Full-Time-Equivalent-Staffing-Prog/ArticleStandard/Article/detail/637543?ref=25</link>

    <description>Rapid Growth of Full Time Equivalent Staffing Programs - Lancaster Whitepaper</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637543null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/House-Committee-Passes-IST-Requirements-in-Chemica/ArticleStandard/Article/detail/637178?ref=25">

    <title>House Committee Passes IST Requirements in Chemical Facility Security Bill</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/House-Committee-Passes-IST-Requirements-in-Chemica/ArticleStandard/Article/detail/637178?ref=25</link>

    <description>The House Energy and Commerce Committee approved H.R. 2868, the &amp;#34;Chemical Facility
    Anti-Terrorism Act of 2009,&amp;#34; a measure to modify and codify existing requirements of the Chemical Facility
    Anti-Terrorism Standards (CFATS) program.</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637178null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Barcode-technology-addresses-the-counterfeit-dilem/ArticleStandard/Article/detail/637255?ref=25">

    <title>Barcode technology addresses the counterfeit dilemma</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling/Barcode-technology-addresses-the-counterfeit-dilem/ArticleStandard/Article/detail/637255?ref=25</link>

    <description>New barcoding technologies are helping to aid product traceability and fight counterfeits. Mark
    Beauchamp of Citizen Systems Europe explains how.</description>

    <dc:date>2009-10-28T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637255/thumbnail_thumbnail.gif</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637255null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Product-profile/ArticleStandard/Article/detail/636757?ref=25">
    <title>Product profile</title>

    <link>http://pharmtech.findpharma.com/pharmtech/Product-profile/ArticleStandard/Article/detail/636757?ref=25</link>

    <description>Acute intoxications require immediate reaction-based on reliable analysis. Shimadzu's TOX.I.S. system
    delivers fast results applying automated process as well as universal sample pre-treatment and identification
    methods</description>

    <dc:date>2009-10-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636757null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Pharmaceutical-Technology-Podcast-Series-on-Supply/ArticleStandard/Article/detail/636866?ref=25">

    <title>Pharmaceutical Technology Podcast Series on Supply-Chain Security</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Pharmaceutical-Technology-Podcast-Series-on-Supply/ArticleStandard/Article/detail/636866?ref=25</link>

    <description />

    <dc:date>2009-10-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636866null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Design-Space-Development-Design-for-Manufacturing-/ArticleStandard/Article/detail/636616?ref=25">

    <title>Achieving Manufacturing Process Excellence with Quality by Design, Design Space Development, Design for
    Manufacturing and PAT - Aegis Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Design-Space-Development-Design-for-Manufacturing-/ArticleStandard/Article/detail/636616?ref=25</link>

    <description>Design Space Development, Design for Manufacturing and PAT - Aegis Whitepaper</description>

    <dc:date>2009-10-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636616null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/ERP-strategies-and-Best-Practices-for-Emerging-Lif/ArticleStandard/Article/detail/636536?ref=25">

    <title>ERP strategies and Best Practices for Emerging Life Science Companies - Ross Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/ERP-strategies-and-Best-Practices-for-Emerging-Lif/ArticleStandard/Article/detail/636536?ref=25</link>

    <description>ERP strategies and Best Practices for Emerging Life Science Companies - Ross Whitepaper</description>

    <dc:date>2009-10-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/636536null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Generics-prevent-innovations-in-pharma/ArticleStandard/Article/detail/635260?ref=25">

    <title>Generics prevent innovations in pharma</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Generics-prevent-innovations-in-pharma/ArticleStandard/Article/detail/635260?ref=25</link>

    <description>Cheaper generic pharmaceuticals, emboldened by US law and patent challenges, restrict novel future
    innovations.</description>

    <dc:date>2009-10-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635260null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Counterfeit-medicines-more-profitable-than-heroin/ArticleStandard/Article/detail/635259?ref=25">

    <title>Counterfeit medicines more profitable than heroin</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Counterfeit-medicines-more-profitable-than-heroin/ArticleStandard/Article/detail/635259?ref=25</link>

    <description>The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press
    conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs,
    which the group is particularly concerned about.</description>

    <dc:date>2009-10-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635259null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/FDA-new-guidance-on-drug-labeling-and-pharmacologi/ArticleStandard/Article/detail/635283?ref=25">

    <title>FDA new guidance on drug labeling and pharmacologic classification</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/FDA-new-guidance-on-drug-labeling-and-pharmacologi/ArticleStandard/Article/detail/635283?ref=25</link>

    <description>The FDA issued a guidance for industry and review staff titled, 'Labeling for Human Prescription Drug
    and Biological Products &amp;amp;#151; Determining Established Pharmacologic Class for Use in the Highlights of
    Prescribing Information'.</description>

    <dc:date>2009-10-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635283null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Pfizer-and-Wyeth-begin-operations-as-a-combined-co/ArticleStandard/Article/detail/635469?ref=25">

    <title>Pfizer and Wyeth begin operations as a combined company</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Pfizer-and-Wyeth-begin-operations-as-a-combined-co/ArticleStandard/Article/detail/635469?ref=25</link>

    <description>Following the completion of its $68-billion acquisition of Wyeth, Pfizer has begun operations at the
    new combined company.</description>

    <dc:date>2009-10-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635469null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Charged-Aerosol-Detection-in-Pharmaceutical-Analys/ArticleStandard/Article/detail/636147?ref=25">

    <title>Charged Aerosol Detection in Pharmaceutical Analysis - Synomics Pharma Whitepaper</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Charged-Aerosol-Detection-in-Pharmaceutical-Analys/ArticleStandard/Article/detail/636147?ref=25</link>

    <description>Charged Aerosol Detection in Pharmaceutical Analysis - Synomics Pharma Whitepaper</description>

    <dc:date>2009-10-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/636147null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Uniting-all-CROs/ArticleStandard/Article/detail/635281?ref=25">

    <title>Uniting all CROs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Uniting-all-CROs/ArticleStandard/Article/detail/635281?ref=25</link>

    <description>US-based CRO, Health Decisions, hopes to raise the efficacy standards for complex studies and help
    companies get products to market faster by establishing an international network of CROs.</description>

    <dc:date>2009-10-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635281null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/EFCG-Counterfeit-Medicines-More-Profitable-than-He/ArticleStandard/Article/detail/635540?ref=25">

    <title>EFCG: Counterfeit Medicines More Profitable than Heroin</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/EFCG-Counterfeit-Medicines-More-Profitable-than-He/ArticleStandard/Article/detail/635540?ref=25</link>

    <description>The European Fine Chemicals Group (EFCG) gave an update of some of its activities at a press
    conference held at CPhI Worldwide (Spain) last week, and revealed some disturbing facts regarding counterfeit APIs,
    which the group is particularly concerned about.</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635540null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/e-solution-broadcast/ArticleStandard/Article/detail/636004?ref=25">

    <title>e-solution broadcast</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/e-solution-broadcast/ArticleStandard/Article/detail/636004?ref=25</link>

    <description>e-solution broadcast</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/636004null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Pharm-Tech-custom-e-newsletter/ArticleStandard/Article/detail/635994?ref=25">

    <title>Pharm Tech custom e-newsletter</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Pharm-Tech-custom-e-newsletter/ArticleStandard/Article/detail/635994?ref=25</link>

    <description>PharmTech custom e-newsletter</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635994null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>PDF</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Pfizer-and-Wyeth-Begin-Operations-as-a-Combined-Co/ArticleStandard/Article/detail/635536?ref=25">

    <title>Pfizer and Wyeth Begin Operations as a Combined Company</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Pfizer-and-Wyeth-Begin-Operations-as-a-Combined-Co/ArticleStandard/Article/detail/635536?ref=25</link>

    <description>Following the completion of its $68-billion acquisition of Wyeth (Madison, NJ), Pfizer (New York)
    began joint operations of the combined company last week.</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635536null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/Regulatory-Roundup-FDA-and-FTC-Issue-Joint-Warning/ArticleStandard/Article/detail/635530?ref=25">

    <title>Regulatory Roundup: FDA and FTC Issue Joint Warning Letter on H1N1 Products</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/Regulatory-Roundup-FDA-and-FTC-Issue-Joint-Warning/ArticleStandard/Article/detail/635530?ref=25</link>

    <description>The two agencies issued a joint Warning Letter to the owners of a website selling unapproved products
    intended to treat the swine flu virus.</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635530null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-New-Guidance-on-Drug-Labeling-and-Pharm/ArticleStandard/Article/detail/635534?ref=25">

    <title>FDA Issues New Guidance on Drug Labeling and Pharmacologic Class</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Issues-New-Guidance-on-Drug-Labeling-and-Pharm/ArticleStandard/Article/detail/635534?ref=25</link>

    <description>The US Food and Drug Administration issued a guidance for industry and review staff titled, Labeling
    for Human Prescription Drug and Biological Products-Determining Established Pharmacologic Class for Use in the
    Highlights of Prescribing Information.</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635534null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


